中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
—— | (3S,6R,7S,8S)-((S,E)-5-(tert-butoxycarbonyl)-2-methyl-1-(2-methylthiazol-4-yl)-pent-1-en-3-yl) 3,7-bis(tert-butyldimethylsilyloxy)-4,4,6,8-tetramethyl-5-oxodec-9-enoate | 1020733-34-9 | C44H78N2O7SSi2 | 835.35 |
12-Aza-epothilones ('Azathilones') 1 and 2 have been prepared through ring-closing olefin metathesis or macrolactonization-based cyclization reactions. While RCM of the respective dienes 9 and 12 was found to be very effective and produced macrocyclic olefins with high E selectivity, the subsequent reduction of the 9,10-double bond proved to be unexpectedly difficult and low-yielding. Preparation of azathilone 2 was also accomplished via macrolactonization and this approach was found to be more effective. Compound 2 is a highly potent inhibitor of human cancer cell growth in vitro. The activity of this analog is comparable with that of Epo A, both in terms of cytotoxicity against drug-sensitive human cancer cells as well as its tubulin-polymerizing activity. However, in contrast to Epo A, 2 is considerably less potent against multidrug-resistant cancer cells.